DJIA 17,698.18 -77.94 -0.44%
NASDAQ 4,880.23 -20.66 -0.42%
S&P 500 2,059.69 -8.20 -0.40%
market minute promo

Amarin Corp plc (ADR) (NASDAQ: AMRN)

2.37 0.03 (1.28%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMRN $2.37 1.28%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.35
Previous Close $2.34
Daily Range $2.28 - $2.39
52-Week Range $0.78 - $3.33
Market Cap $419.7M
P/E Ratio -6.50
Dividend (Yield) $0.00 (0.0%)
Volume 1,966,493
Average Daily Volume 8,819,771
Current FY EPS -$0.39




Drug Makers

Amarin Corp plc (ADR) (AMRN) Description

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders. Website:

News & Commentary Rss Feed

Should Investors Toss in the Towel on Amarin Corp Plc?

Awash with possibilities a decade ago, Amarin ultimately fell as low as $1 per share; tune in to find out what happened.

Amarin: A Look At The Recent Selloff And Negative Perceptions

European ADRs Flat as Pharma Gains Are Outweighed By Mining Losses

European ADRs Higher as Eurozone Growth Gathers Pace

Shake Shack Shares Persist On The Hard To Borrow List

Biotech Stocks: 2 to Avoid, 1 to Buy

Motley Fool contributor Todd Campbell offers insight on three biotech stocks, including two that investors should stay away from.

Amarin's Case Vs. FDA Will Garner Positive Attention

Benzinga's Top #PreMarket Losers

European ADRs Lower Despite Mixed Results for Oil Stocks

Amarin Argues In Court For Vascepa Exclusivity

See More AMRN News...

AMRN's Top Competitors

AMRN $2.37 (1.28%)
Current stock: AMRN
JNJ $99.15 (-1.44%)
Current stock: JNJ
NVS $99.86 (1.27%)
Current stock: NVS
RHHBY $34.55 (0.48%)
Current stock: RHHBY